Sökning: WFRF:(Hjortland G. O.) >
International compa...
International comparison of treatment strategy and survival in metastatic gastric cancer
-
- Claassen, Y. H. M. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands
-
- Bastiaannet, E. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands;Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands
-
- Hartgrink, H. H. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands,Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands,Belgian Canc Registry, Brussels, Belgium,Natl Qual Improvement Programme RKKP, Danish Natl Registries, Aarhus, Denmark,Royal Marsden NHS Fdn Trust, Dept Surg, London, England
-
visa fler...
-
- Dikken, J. L. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands
-
- de Steur, W. O. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands
-
- Slingerland, M. (författare)
- Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands
-
- Verhoeven, R. H. A. (författare)
- Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands
-
- van Eycken, E. (författare)
- Belgian Canc Registry, Brussels, Belgium
-
- de Schutter, H. (författare)
- Belgian Canc Registry, Brussels, Belgium
-
- Lindblad, M. (författare)
- Karolinska Institutet,Karolinska Univ Hosp, Dept Surg Gastroenterol, Stockholm, Sweden
-
- Hedberg, Jakob, 1972- (författare)
- Uppsala universitet,Gastrointestinalkirurgi
-
- Johnson, E. (författare)
- Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway;Oslo Univ Hosp, Dept Paediat Surg, Oslo, Norway;Oslo Univ Hosp, Dept Oncol, Oslo, Norway
-
- Hjortland, G. O. (författare)
- Univ Oslo, Inst Clin Med, Oslo, Norway
-
- Jensen, L. S. (författare)
- Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark
-
- Larsson, H. J. (författare)
- Natl Qual Improvement Programme RKKP, Danish Natl Registries, Aarhus, Denmark
-
- Koessler, T. (författare)
- Geneva Univ Hosp, Dept Med Oncol, Geneva, Switzerland
-
- Chevallay, M. (författare)
- Geneva Univ Hosp, Dept Surg, Geneva, Switzerland
-
- Allum, W. H. (författare)
- Royal Marsden NHS Fdn Trust, Dept Surg, London, England
-
- van de Velde, C. J. H. (författare)
- Leiden Univ, Med Ctr, Dept Surg, K6-R,POB 9600, NL-2300 RC Leiden, Netherlands
-
visa färre...
-
(creator_code:org_t)
- 2018-10-09
- 2019
- Engelska.
-
Ingår i: BJS Open. - : JOHN WILEY & SONS LTD. - 2474-9842. ; 3:1, s. 56-61
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://bjssjournals...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BackgroundIn the randomized Asian REGATTA trial, no survival benefit was shown for additional gastrectomy over chemotherapy alone in patients with advanced gastric cancer with a single incurable factor, thereby discouraging surgery for these patients. The purpose of this study was to evaluate treatment strategies for patients with metastatic gastric cancer in daily practice in five European countries, along with relative survival in each country. MethodsNationwide population-based data from Belgium, Denmark, the Netherlands, Norway and Sweden were combined. Patients with primary metastatic gastric cancer diagnosed between 2006 and 2014 were included. The proportion of gastric resections performed and the administration of chemotherapy (irrespective of surgery) within each country were determined. Relative survival according to country was calculated. ResultsOverall, 15 057 patients with gastric cancer were included. The proportion of gastric resections varied from 81 per cent in the Netherlands and Denmark to 183 per cent in Belgium. Administration of chemotherapy was 392 per cent in the Netherlands, compared with 632 per cent in Belgium. The 6-month relative survival rate was between 390 (95 per cent c.i. 378 to 402) per cent in the Netherlands and 541 (521 to 569) per cent in Belgium. ConclusionThere is variation in the use of gastrectomy and chemotherapy in patients with metastatic gastric cancer, and subsequent differences in survival.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
BJS Open
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Claassen, Y. H. ...
-
Bastiaannet, E.
-
Hartgrink, H. H.
-
Dikken, J. L.
-
de Steur, W. O.
-
Slingerland, M.
-
visa fler...
-
Verhoeven, R. H. ...
-
van Eycken, E.
-
de Schutter, H.
-
Lindblad, M.
-
Hedberg, Jakob, ...
-
Johnson, E.
-
Hjortland, G. O.
-
Jensen, L. S.
-
Larsson, H. J.
-
Koessler, T.
-
Chevallay, M.
-
Allum, W. H.
-
van de Velde, C. ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
BJS Open
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet